Neuroscience

SIFT HEALTHCARE ANNOUNCES PARTNERSHIP WITH HARTFORD HEALTHCARE TO APPLY AI AND ADVANCED ANALYTICS TO REDUCE REIMBURSEMENT RISK

Strategic partnership focuses on preventing denials and other adverse payment outcomes earlier in the revenue cycle.MILWAUKEE and HARTFORD, Conn., Feb....

Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.

BELFAST, Northern Ireland, Feb. 10, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on...

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities

Roche’s fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the...

The Rainwater Charitable Foundation Announces 2026 Rainwater Prize Winners, Advancing Research in Primary Tauopathies and Neurodegenerative Disease

Strategic investments in tau and neurodegenerative research aim to accelerate scientific discoveries and drive progress toward the development of new...

Cognision Launches Cognision360™: A Unified Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into...

error: Content is protected !!